Biogen (BIIB) free cash flow was $2.0B in FY2025 (-20% YoY). The tables below show the complete quarterly and annual free cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Free Cash Flow
Fiscal Year
Free Cash Flow
YoY
2025
$2.0B
-20%
2024
$2.5B
+104%
2023
$1.2B
+8%
2022
$1.1B
-66%
2021
$3.4B
-10%
2020
$3.8B
-41%
2019
$6.4B
+18%
2018
$5.4B
+100%
2017
$2.7B
-29%
2016
$3.8B
+16%
2015
$3.3B
+24%
2014
$2.6B
+326%
2013
-$1.2B
-172%
2012
$1.6B
+7%
2011
$1.5B
+5%
2010
$1.5B
+60%
2009
$909M
-29%
2008
$1.3B
+75%
2007
$735M
Recent Quarterly Free Cash Flow
Quarter
Free Cash Flow
Q1 2026
$594M
Q4 2025
$452M
Q3 2025
$1.2B
Q2 2025
$134M
Q1 2025
$212M
Q4 2024
$695M
Q3 2024
$806M
Q2 2024
$583M
Q1 2024
$432M
Q4 2023
-$53M
Q3 2023
$505M
Q2 2023
$400M
Source: BIIB on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.